Enteq Upstream PLC

Director/PDMR Shareholding

RNS Number : 7693U
Enteq Upstream PLC
31 July 2020
 

Enteq Upstream plc

(the "Company")

 

Director Shareholding

 

 

The Company received notification on 31 July 2020 that David Steel, Finance Director, acquired 75,000 ordinary shares of 1p each in the Company ("Ordinary Shares") at a price of 12p per Ordinary Share on 31 July 2020.  Following this acquisition, Mr Steel has an interest in 1,526,741 Ordinary Shares, representing approximately 2.3 per cent. of the Company's issued ordinary share capital.

 

 

 

 

For further information, please contact:

 

Enteq Upstream plc

+44 (0)1494 618739

Martin Perry, Chief Executive Officer


David Steel, Finance Director

 

 


Investec Bank plc (NOMAD and Broker)

+44 (0)207 597 4000

Chris Treneman, Patrick Robb, David Anderson




 



 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

David Steel

 

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Enteq Upstream

b)

LEI

2138006BKS2MOAPRUB75

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1 pence each

 

GB00B41Q8Q68

b)

Nature of the transaction

Purchase

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.12

75,000

d)

Aggregated information

Not applicable - single transaction

e)

Date of the transaction

31 July 2020

f)

Place of the transaction

London Stock Exchange

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHFIFFADEILVII